Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Assets Average (2021 - 2023)

Historic Assets Average for Terns Pharmaceuticals (TERN) over the last 3 years, with Q3 2023 value amounting to $280.7 million.

  • Terns Pharmaceuticals' Assets Average rose 6636.26% to $280.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $280.7 million, marking a year-over-year increase of 6636.26%. This contributed to the annual value of $227.5 million for FY2022, which is 7479.49% up from last year.
  • As of Q3 2023, Terns Pharmaceuticals' Assets Average stood at $280.7 million, which was up 6636.26% from $295.5 million recorded in Q2 2023.
  • Terns Pharmaceuticals' Assets Average's 5-year high stood at $295.5 million during Q2 2023, with a 5-year trough of $145.8 million in Q1 2021.
  • Its 3-year average for Assets Average is $208.1 million, with a median of $183.9 million in 2021.
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 2213.54% in 2022, then soared by 9599.51% in 2023.
  • Over the past 3 years, Terns Pharmaceuticals' Assets Average (Quarter) stood at $174.0 million in 2021, then soared by 37.84% to $239.8 million in 2022, then grew by 17.05% to $280.7 million in 2023.
  • Its Assets Average stands at $280.7 million for Q3 2023, versus $295.5 million for Q2 2023 and $294.2 million for Q1 2023.